Naobios
Your partner in the production
of virus-based products
Naobios is a GMP-certified company with a wide experience in bioprocess development and contract manufacturing services of preclinical & clinical batches for virus-based products such as viral vectors, viral vaccines (live or inactivated), oncolytic viruses & challenge agents.
In the news
See all news
Whitepaper – March 2026
Oncolytic Viruses: From Scientific Breakthrough to Manufacturing Reality - by Thibaud DAUPHIN
Oncolytic viruses (OV) represent a transformative class of cancer therapeutics designed to selectively infect, replicate within, and destroy malignant cells while stimulating systemic antitumor immunity. Advances in genetic engineering have further enhanced the antitumor potential of OV by enabling the delivery of therapeutic payloads, improving tumor cell selectivity, and even evading neutralization by the host immune system.
Press Release – SGS x Naobios – March 2026
Naobios and SGS partner to manufacture Respiratory Syncytial Virus (RSV) challenge agent
Collaboration supports Controlled Human Infection Model (CHIM) studies that help accelerate development of effective and affordable RSV vaccines
Clean Biologics was born in 2018 from a fruitful alliance between Clean Cells and Archimed. Through this partnership, the group soon acquired and integrated CDMO Naobios to extend the service offer and to promote our future-oriented thinking. The expertise, transparency, progress and a human-centred view are at the core of our identity. Day after day, we use our knowledge and our skills to deliver high-quality services in innovative projects with an unwavering dynamism and commitment.